342 related articles for article (PubMed ID: 24646400)
1. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?
Ahmed MH; Ali A
Scand J Gastroenterol; 2014 May; 49(5):521-7. PubMed ID: 24646400
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease as a multi-systemic disease.
Fotbolcu H; Zorlu E
World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
[TBL] [Abstract][Full Text] [Related]
5. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.
Simon TG; Corey KE; Chung RT; Giugliano R
Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510
[TBL] [Abstract][Full Text] [Related]
8. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
Lim S; Oh TJ; Koh KK
Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
Luo J; Xu L; Li J; Zhao S
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area.
Vilar CP; Cotrim HP; Florentino GS; Bragagnoli G; Schwingel PA; Barreto CP
Arq Gastroenterol; 2015; 52(2):111-6. PubMed ID: 26039828
[TBL] [Abstract][Full Text] [Related]
12. The association between renal stone disease and cholesterol gallstones: the easy to believe and not hard to retrieve theory of the metabolic syndrome.
Ahmed MH; Barakat S; Almobarak AO
Ren Fail; 2014 Jul; 36(6):957-62. PubMed ID: 24678942
[TBL] [Abstract][Full Text] [Related]
13. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
14. Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease.
Potze W; Siddiqui MS; Sanyal AJ
Semin Thromb Hemost; 2015 Jul; 41(5):488-93. PubMed ID: 26049073
[TBL] [Abstract][Full Text] [Related]
15. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.
Yilmaz Y; Ayyildiz T; Akin H; Colak Y; Ozturk O; Senates E; Tuncer I; Dolar E
Gut Liver; 2014 May; 8(3):313-7. PubMed ID: 24827629
[TBL] [Abstract][Full Text] [Related]
16. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
[TBL] [Abstract][Full Text] [Related]
17. Serum Plant Sterols Associate with Gallstone Disease Independent of Weight Loss and Non-Alcoholic Fatty Liver Disease.
Käkelä P; Männistö V; Ilves I; Vaittinen M; Tauriainen MM; Eskelinen M; Gylling H; Paajanen H; Pihlajamäki J
Obes Surg; 2017 May; 27(5):1284-1291. PubMed ID: 27812789
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship.
Arrese M; Cortés V; Barrera F; Nervi F
Curr Opin Gastroenterol; 2018 Mar; 34(2):90-96. PubMed ID: 29266009
[TBL] [Abstract][Full Text] [Related]
19. Macronutrients and insulin resistance in cholesterol gallstone disease.
Tsai CJ; Leitzmann MF; Willett WC; Giovannucci EL
Am J Gastroenterol; 2008 Nov; 103(11):2932-9. PubMed ID: 18853969
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
